scholarly journals The Effect of Dietary Vitamin D3 Level on Bone Osteometry and Mechanical Properties in Young Rats

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A237-A238
Author(s):  
Siemowit Muszyński ◽  
Małgorzata Świątkiewicz ◽  
Beata Szymczyk ◽  
Maria Oczkowicz ◽  
Iwona Furgał-Dzierżuk

Abstract Recent knowledge indicates that vitamin D3 not only regulates the calcium-phosphate metabolism, but also as a hormone with steroidal features, has significant remedial-homeostatic ability and has a pleiotropic function in the body. Medical observations confirm the beneficial effect of elevated levels of vitamin D3 in the prevention or alleviation of the course of many diseases of the cancer and autoimmune basis, diabetes and coronary diseases. The deficiencies of this vitamin in children, adolescents and young women are observed, causing the rickets or bone fragility. As the increasingly limited role of obtaining vitamin D3 from the sun exposure, supplementation of food sources becomes particularly important. The aim of the study was to evaluate the effect of the increased dietary vitamin D3 level on health status using rats as the model animals. The experiment was carried out on 36 weaned rat Wistar, half female and male, 5–6 weeks old. Animals were divided into 3 groups. All rats obtained ad libitum the same feed mixture but differed in the vitamin D3 level (0, 1000 or 5000 IU/kg). Bone length and weight, cross-section area and wall thickness were measured, cortical index was calculated. The mechanical properties were determined using the 3-point bending test performed on a universal testing machine (Zwick Z010). The supports were placed at 40% of the total bone length and the measuring head loaded bone samples with a constant speed of 10 mm/min until fracture. The bone mineral density was determined using the dual-energy X-ray absorptiometry (DEXA) method on a DiscoveryWHologic X-ray densitometer. We observed that, the vitamin D3 presence in feed did not significantly affect the bone geometrical traits in young rats. The vitamin D3 supplementation, regardless its level, increased the bone mineral density by 8–12% (P<0.05) and some mechanical properties were improved (P<0.05) in comparison to group without vitamin D3 supplementation. Also, the femur bone of rats supplemented with vitamin D3 characterised by the higher share force (11–14%), work needed for destruction (24–55%), ultimate strain, ultimate stress (5–7%). The bone elastic strength was the highest in group III, receiving the vitamin D3 in amount excessing the standard requirement of rats. Summerizing it can be concluded, contrary to the assumptions, we did not confirmed the significant effect of increased vitamin D3 level in feed on MBD and most of the mechanical traits. However, the maximal elastic strenght was the highest in group receiving 5000 IU/kg of vitamin D3, which reflects the highest elastic strength of midshaft cortical bone under reversible deformation and the maximum stress which a bone can withstand before fracture, but the difference was not statistically confirmed.

2008 ◽  
Vol 51 (4) ◽  
pp. B35
Author(s):  
Cortney Bosworth ◽  
Laura Kooienga ◽  
Jessica Kendrick ◽  
Gerard Smits ◽  
Michel Chonchol

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Yvonne Haba ◽  
Ralf Skripitz ◽  
Tobias Lindner ◽  
Martin Köckerling ◽  
Andreas Fritsche ◽  
...  

The bone mineral density (BMD) of retrieved cancellous bone samples is compared to the BMD measuredin vivoin the respective osteoarthritic patients. Furthermore, mechanical properties, in terms of structural modulus (Es) and ultimate compression strength (σmax) of the bone samples, are correlated to BMD data. Human femoral heads were retrieved from 13 osteoarthritic patients undergoing total hip replacement. Subsequently, the BMD of each bone sample was analysed using dual energy X-ray absorptiometry (DXA) as well as ashing. Furthermore, BMDs of the proximal femur were analysed preoperatively in the respective patients by DXA. BMDs of the femoral neck and head showed a wide variation, from1016±166 mg/cm2to1376±404 mg/cm2. BMDs of the bone samples measured by DXA and ashing yielded values of315±199 mg/cm2and347±113 mg/cm3, respectively.Esandσmaxamounted to232±151 N/mm2and6.4±3.7 N/mm2. Significant correlation was found between the DXA and ashing data on the bone samples and the DXA data from the patients at the femoral head (r=0.85and 0.79, resp.).Escorrelated significantly with BMD in the patients and bone samples as well as the ashing data (r=0.79,r=0.82, andr=0.8, resp.).


Author(s):  
Gabriella Martino ◽  
Federica Bellone ◽  
Carmelo M. Vicario ◽  
Agostino Gaudio ◽  
Andrea Caputo ◽  
...  

Clinical psychological factors may predict medical diseases. Anxiety level has been associated with osteoporosis, but its role on bone mineral density (BMD) change is still unknown. This study aimed to investigate the association between anxiety levels and both adherence and treatment response to oral bisphosphonates (BPs) in postmenopausal osteoporosis. BMD and anxiety levels were evaluated trough dual-energy X-ray absorptiometry and the Hamilton Anxiety Rating Scale (HAM-A), respectively. Participants received weekly medication with alendronate or risedronate and were grouped according to the HAM-A scores into tertiles (HAM-A 3 > HAM-A 2 > HAM-A 1). After 24 months, BMD changes were different among the HAM-A tertiles. The median lumbar BMD change was significantly greater in both the HAM-A 2 and HAM-A 3 in comparison with the HAM-A 1. The same trend was observed for femoral BMD change. Adherence to BPs was >75% in 68% of patients in the HAM-A 1, 79% of patients in the HAM-A 2, and 89% of patients in the HAM-A 3 (p = 0.0014). After correcting for age, body mass index, depressive symptoms, and the 10-yr. probability of osteoporotic fractures, anxiety levels independently predicted lumbar BMD change (β = 0.3417, SE 0.145, p = 0.02). In conclusion, women with higher anxiety levels reported greater BMD improvement, highlighting that anxiety was associated with adherence and response to osteoporosis medical treatment, although further research on this topic is needed.


2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 227.2-228
Author(s):  
D. Claire ◽  
M. Geoffroy ◽  
L. Kanagaratnam ◽  
C. Isabelle ◽  
A. Hittinger ◽  
...  

Background:Dual energy X-ray absoprtiometry is the reference method to mesure bone mineral density (1). Loss of bone mineral density is significant if it exceeds the least significant change. The threshold value used in general population is 0,03 g/cm2 (2). Patients with obesity are known for having a higher bone mineral density due to metabolism and physiopathology characteristics (3,4).Objectives:The aim of our study was to determine the least significant change in bone densitometry in patients with obesity.Methods:We conducted an interventionnal study in 120 patients with obesity who performed a bone densitometry. We measured twice the bone mineral density at the lumbar spine, the femoral neck and the total hip in the same time (5,6). We determined the least significant change in bone densitometry from each pair of measurements, using the Bland and Altman method. We also determined the least significant change in bone densitometry according to each stage of obesity.Results:The least significant change in bone densitometry in patients with obesity is 0,046g/cm2 at the lumbar spine, 0.069 g/cm2 at the femoral neck and 0.06 g/cm2 at the total hip.Conclusion:The least significant change in bone densitometry in patients with obesity is higher than in general population. These results may improve DXA interpretation in this specific population, and may personnalize their medical care.References:[1]Lees B, Stevenson JC. An evaluation of dual-energy X-ray absorptiometry and comparison with dual-photon absorptiometry. Osteoporos Int. mai 1992;2(3):146-52.[2]Briot K, Roux C, Thomas T, Blain H, Buchon D, Chapurlat R, et al. Actualisation 2018 des recommandations françaises du traitement de l’ostéoporose post-ménopausique. Rev Rhum. oct 2018;85(5):428-40.[3]Shapses SA, Pop LC, Wang Y. Obesity is a concern for bone health with aging. Nutr Res N Y N. mars 2017;39:1-13.[4]Savvidis C, Tournis S, Dede AD. Obesity and bone metabolism. Hormones. juin 2018;17(2):205-17.[5]Roux C, Garnero P, Thomas T, Sabatier J-P, Orcel P, Audran M, et al. Recommendations for monitoring antiresorptive therapies in postmenopausal osteoporosis. Jt Bone Spine Rev Rhum. janv 2005;72(1):26-31.[6]Ravaud P, Reny JL, Giraudeau B, Porcher R, Dougados M, Roux C. Individual smallest detectable difference in bone mineral density measurements. J Bone Miner Res. août 1999;14(8):1449-56.Disclosure of Interests:None declared.


Sign in / Sign up

Export Citation Format

Share Document